OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
With the growing energy needs in Asia well documented and an emphasis on environmentally-friendly avenues in which to meet those demands now a standard a window of opportunity for companies specializing in clean energy technology has emerged. One such company, … Continue reading →
Questions surrounding Cell Therapeutics Inc. (NASDAQ: CTIC) abound as investors continue to place their bets on whether the biopharmaceutical company has the ability to eliminate questions of effectiveness and safety concerning their lymphoma drug pixantrone and bring the drug to market. Continue reading →
While it’s been nearly five years since Samson Oil & Gas (AMEX: SSN) could boast of a profit in their financial reports the Australian-based oil and gas company has, over time, acquired a number of promising assets that could quickly turn their fortunes. Those assets are grounded almost exclusively in the United States as the company holds extensive development and exploration acreage throughout the country and with several of those properties showing promise Samson Oil & Gas has found itself gaining investor confidence.
Continue reading →
It has been less than a month since the board of directors of Evergreen Energy (NYSE Arca: EEE) approved the execution of a reverse split of its common shares at a ratio of 1-for-12, and just under two weeks since … Continue reading →
A number of factors have contributed to the recent change in tune of analysts as it concerns SIRIUS XM Radio (NASDAQ: SIRI) not the least of which being the satellite-radio provider’s upcoming end to a three-year commitment to freeze their … Continue reading →
While securing U.S. FDA market clearance is central to market entry and product acceptance it doesn’t come easy as the governmental regulatory agency has been known to take its time on giving the green light to just about any type of device … Continue reading →
Posted in Articles, Penny Stocks, Pink Sheets, Stocks to Watch
|
Tagged biel, bioelectronics, fda, financial statements, investors, over-the-counter, pain management therapeutics, Pink Sheets
|
Late Monday afternoon a U.S. district court in Washington issued a preliminary injunction stopping federal funding of human embryonic stem cell research, casting a shadow of doubt in the minds of investors concerning biotechnology companies specializing in the controversial field of regenerative medicine. Continue reading →
Earlier this month international transportation service giant YRC Worldwide Inc. (NASDAQ: YRCW) completed the initial closing on the sale of a portion of its YRC Logistics brand, generating gross proceeds of approximately $38.7 million yet the financial stability of the Overland Park, Kansas-based company remains uncertain as it continues to try and drive itself out of the economic slump that nearly bankrupted the company last December. Continue reading →
Cord Blood America, Inc. (OTCBB: CBAI) has enjoyed tremendous success in 2010, capitalizing on the acquisition of 51 percent of the total outstanding shares of the private German company stellacure GmbH, a firm that collects, processes and stores cord blood for use in Germany, Spain and Italy as well as other European and Middle Eastern countries. Continue reading →
Posted in Articles, OTC Bulletin Board, Penny Stocks, Stocks to Watch
|
Tagged CBAI, otc, otcbb, over-the-counter, penny stock, penny stocks, stocks, trading
|
Few things can be as reassuring to a penny stocks investor as a deal struck by one of their investments and an established heavyweight trading on the NYSE. For investors in Positron Corp. (OTCBB: POSC) Thursday was a good day as the company announced they had signed an agreement with Covidien (NYSE: COV) that will better assist the nano-cap company with the development of technology to automate the compounding of radiopharmaceuticals. Continue reading →
